Search Results 141-150 of 15006 for Tamoxifen

  1. Study May Help Cool Hot Flashes

    Loprinzi has pioneered the field of nonhormonal hot flash therapy, which he began researching decades ago to help breast cancer patients using tamoxifen, an ...

  2. Medical Research & Education - Mayo Clinic News Network

    Dana Sparks. February 1, 2018. New international practice guidelines for tamoxifen treatment based on CYP2D6 genotype featured image. Cancer. New international ...

  3. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  4. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  5. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  6. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  7. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  8. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  9. A Study To Measure The Proteins Expressed In Tissue Samples From Women Who Have Been Treated With New Endocrine Therapy For Invasive Lobular Breast Cancer - Mayo Clinic

    The purpose of this study is to compare the effectiveness of fulvestrant to anastrozole or tamoxifen in treating invasive lobular breast cancer, by ...

  10. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.